TREATMENT OF ACTINIC KERATOSIS AT THE PRESENT STAGE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The choice of treatment for actinic keratosis (AK) depends on the clinical form, localization of lesion, associated diseases and economic opportunities. Treatment of AK by laser-induced thermotherapy is of great interest. This article discusses the currently used methods of AK treatment. Description of the clinical case. A clinical case of treating a patient with a diagnosis of actinic keratosis, erythematous form is presented. According to the results of a cytological examination, changes in the dermis were represented by keratinocyte dysplasia and hyperkeratosis. Ultrasound of the AK lesion revealed an increase in the thickness of the epidermis in the form of a band of increased echogenicity and hypoechoic zone, which occupies a third of the dermis, corresponding to solar elastosis. The patient received AK treatment using laser-induced thermotherapy with a good clinical and cosmetic results. Conclusion. The prevalence of the disease, risk of malignant transformation, the patient’s awareness of cosmetic unacceptability, the adverse effect on the psycho-emotional sphere and social adaptation determine the relevance of this problem and the need to develop new effective methods and treatment regimens.

Full Text

Restricted Access

About the authors

T. E Sukhova

Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

M. I Fedoseeva

Moscow Regional Scientific Research Clinical Institute n.a. M.F. Vladimirsky

Email: MIF310891@mail.ru
Postgraduate Student, Department of Dermatology and Venereology

References

  1. Zaiaudek I., Piana S., Moscarella E., et ai. Morphologic grading and treatment of facial actinic keratosis. Clin. Dermatol. 2014; 32(1):80-7.
  2. Siegel J.A., Korgavkar K., Weinstock M.A. Current perspective on actinic keratosis: a review. Br. J. Dermatol. 2016;177(2):1-9. Doi 10.1111/ bjd.14852.
  3. Rigel D.S., Stein Gold L.F. The importance of early diagnosis and treatment of actinic keratosis. J. Am. Acad. Dermatol. 2013;68:20-7.
  4. Micali G., Lacarrubba F., Nasca M.R., et al. Topical pharmacotherapy for skin cancer. Part II. Clinical applications. J. Am. Acad. Dermatol. 2014;70(6):979e1-979e12. Doi: 10.1016/j. jaad.2013.12.037lss.
  5. Werner R.N., Sammain A., Erdmann R., et al. The natural history of actinic keratosis: a systematic review. Br. J. Dermatol. 2013;169(3):502-518. doi: 10.1111/bjd.12420.
  6. Schaefer I., Augustin M., Spehr C., et al. Prevalence and risk factors of actinic keratoses in Germany -analysis of multisource data. J. Eur. Acad. Dermatol. Venereol. 2013;28:309-13. Doi: 10.1111/ jdv. 12102.
  7. Rogers H.W., Weinstock M.A., Feldman S.R., Coldiron B.M. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012. J. Am. Med. Ass. Dermatol. 2015;151(10):1081-86. Doi:10.1001/ jamadermatol. 2015.1187.
  8. Ferrandiz C., Fonseca-Capdevila E., Garcfa-Diez A., et al. Spanish Adaptation of the European Guidelines for the Evaluation and Treatment of Actinic Keratosis. Actas Dermosifiliogr. 2014;105(4):378-93.
  9. Green A.C. Epidemiology of Actinic Keratoses. J. Curr. Probl. Dermatol. 2015;46:1-7. doi: 10.1159/000366525.
  10. Philipp-Dormston W.G. Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis. J. Cur. Probl. Dermatol. 2015;46:115-21 doi: 10.1159/000366547.
  11. Ceilley R.I., Jorizzo J.L. Current issues in the management of actinic keratosis. J. Am. Acad. Dermatol. 2013;6(1:28-38). Doi: 10.1016/j. jaad.2012.09.051.
  12. Dirschka T., Radny P., Dominicus R., et al.; AK-CT002 Study Group; AK-CT003 Study Group. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br. J. Dermatol. 2013;168(4):825-36. doi: 10.1111/bjd.12158.
  13. Pomerantz H., Hogan D., Eilers D., et al.; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis. A Randomized Clinical Trial. JAMA. Dermatol. 2015;15 (9):9-960. Doi: 10.1001/ jamadermatol.2015.0502.
  14. Dreno B., Amici J.M., Basset-Seguin N., et al. Management of actinic keratosis: a practical report and treatment algorithm from AKTeamTM expert clinicians. J. Eur. Acad. Dermatol. Venereol. 2014;28(9):1141-9. Doi: 10.1111/ jdv. 12434.
  15. Costa C., Scalvenzi M., Ayala F., et al. How to treat actinic keratosis? An update. J. Dermatol. Case Reports. 2015;9(2):29-35. Doi: http://dx.doi. org/10.3315/jdcr.2015.1199.
  16. Lacour J.P., Ulrich C., Gilaberte Y., et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J. Eur. Acad. Dermatol. Venereol. 2015;29(12):2342-48. Doi: 10.1111/ jdv.13228.
  17. Morton C.A., Szeimies R.M., Sidoroff A., Braathen L.R. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 2013;27(5):536-44. Doi: 10.1111/ jdv. 12031.
  18. Morton C.A., Wulf H.C., Szeimies R.M., et al. Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus. J. Eur. Acad. Dermatol. Venereol. 2015;29:1718-23. doi: 10.1111/jdv.12974.
  19. Shergill B., Zokaie S., Carr A.J. Non-adherence to topical treatmentsfor actinic keratosis. Patient Prefer. Adher. 2014;8:35-41. doi: 10.2147/PPA. S47126.
  20. Rigel D.S., Stein Gold L.F. The importance of early diagnosis and treatment of actinic keratosis. J. Am. Acad. Dermatol. 2012;68(1):21-7. doi: 10.1016/j.jaad.2012.10.001.
  21. Vegter S., Tolley K. A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe. PLOS ONE. 2014;9(6). doi: 10.1371/journal.pone.0096829.
  22. Werner R.N., Stockfleth E., Connolly S.M., et al. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. J. Eur. Acad. Dermatol. Venereol. 2015;29:2069-79. Doi: 10.1111/ jdv.13180.
  23. Strunk T., Braathen L.R., Szeimies R.-M. Актинический кератоз - обзор литературы. Вестник дерматологии и венерологии. 2014;5:42-52.
  24. Сухова Т.Е., Молочков В.А., Романко Ю.С. и др. Фотодинамическая терапия актинического кератоза с аппликационным применением «Фотодитазина». Российский журнал кожных и венерических болезней. 2010;(5)5.
  25. Казанцева К.В., Молочков А.В., Молочков В.А. и др. Саркома Капоши: патогенез, клиника, диагностика и современные принципы лечения. Российский журнал кожных и венерических болезней. 2015;18(1):7-15.
  26. Молочков В.А., Молочков А.В., Сухова Т.Е. и др. Лазериндуцированная термотерапия базалиомы. Российский журнал кожных и венерических болезней. 2012;2:6-10. [
  27. Каприн А.Д., Галкин В.Н., Жаворонков Л.П. и др. Синтез фундаментальных и прикладных исследований - основа обеспечения высокого уровня научных результатов и внедрения их в медицинскую практику. Радиация и риск. 2017;26(2):26-40.
  28. Молочков А.В., Каприн А.Д., Галкин В.Н. и др. Лечение базально-клеточной карциномы с использованием фотодинамической терапии и локальным применением фотосенсибилизатора фотолон. Радиация и риск. 2015;24(1 ):108-17.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies